Know What's Happening in BioTech
Know What's Happening in BioTech
BioTech Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
HighRes and Opentrons have formed a strategic partnership to create the industry’s first AI agent‑to‑agent laboratory automation workflow, linking software‑driven experiment design directly to physical execution. The integration combines Opentrons’ modular robotic platforms and AI‑enabled protocol tools with HighRes’ orchestration and scheduling software, enabling end‑to‑end, scalable lab workflows. Both companies will showcase a live demonstration at SLAS 2026, emphasizing open APIs and interoperability. The solution aims to move from natural‑language intent to reliable bench execution while maintaining regulatory‑grade repeatability.
GSK’s new CEO Luke Miels announced the company will not pursue GLP‑1 obesity drugs, citing a crowded market and pipeline misalignment. Instead, GSK is concentrating on the downstream complications of obesity, particularly liver disease, after acquiring Boston Pharmaceuticals’ efimosfermin alfa...
Eli Lilly reported fourth‑quarter revenue of $19.3 billion, driven by a 46 % surge in volume of its GLP‑1 drugs Mounjaro and Zepbound. Earnings per share rose to $7.54, comfortably beating the $6.91 consensus. The two drugs together generated $11.7 billion, lifting the company’s...
Scientists at Tokyo University of Science have shown that endophytic bacteria can coexist with plant cell cultures and unlock dormant metabolic pathways. Co‑culturing tobacco BY‑2 cells with Delftia sp. BR1R‑2 triggered a surge in acetophenone derivatives and altered phenolic profiles...
QT Sense, a Dutch biotech startup, closed a €4 million seed round led by Cottonwood Technology Fund, supplemented by an ONCO‑Q grant and the Quantum Forward Challenge. The capital will accelerate development of Quantum Nuova, a nanodiamond‑based quantum‑sensing platform that provides real‑time,...
Elisabeth Gardiner, CSO of Tevard Biosciences, warned that women remain vastly under‑represented in pharmaceutical STEM roles, occupying only 20‑30% of such positions despite comprising half of the U.S. workforce. She highlighted a "confidence paradox" where girls' interest in STEM has...
A recent clinical review evaluates the optimal timing for performing neonatal gastrostomy concurrently with tracheostomy. The authors compare outcomes of simultaneous versus staged procedures, highlighting reduced anesthesia exposure and shorter intensive care stays when both are done together. Data from...
Luke Miels’ first financial update as GSK chief executive shows an 8% rise in fourth‑quarter sales to £8.62 bn, lifting full‑year revenue 7% to £32.67 bn. Growth was driven by new launches such as Blenrep, Nucala and Exdensur, and a pipeline bolstered...
Expert Intelligence announced a $4.7 million seed round to commercialize its Limited Sample Model (LSM), an AI platform that automates decision‑making in regulated laboratory environments. LSM learns from as few as 30 representative samples, enabling labs to transform raw instrument data...
Novartis announced that generic competition will erode about $4 billion from its 2026 sales, primarily affecting three blockbuster drugs. The heart‑failure medication Entrezto, its top seller, will see its first generic entry in the fourth quarter of 2026. The company warned...
Researchers in Nature Neuroscience reveal how neural populations encode multiple tasks using shared geometric structures. By mapping firing rates into high‑dimensional spaces, they show that tasks with latent commonalities are represented in low‑dimensional subspaces, while task‑specific components occupy orthogonal higher‑dimensional...
Eli Lilly reported fourth‑quarter 2025 revenue that topped analysts’ forecasts, signaling a stronger‑than‑expected performance. The company also projected a sizable revenue increase for 2026, driven by upcoming product launches and an expanding oncology pipeline. This upbeat guidance contrasts sharply with Novo Nordisk’s...
Australian researchers have engineered antibodies that bind to pseudaminic acid, a sugar molecule found exclusively on the surface of many pathogenic bacteria. The pan‑specific antibody demonstrated potent clearance of multidrug‑resistant Acinetobacter baumannii in mouse infection models. By targeting a bacterial...
Researchers at Rice University engineered a naphthoquinone‑grafted chitosan hydrogel that embeds the food‑grade bacterium Lactiplantibacillus plantarum, achieving extracellular electron transfer 15.6 times higher than plain chitosan. The tethered quinone mediators stay fixed, preventing leakage and stabilizing performance for up to...
A new study in Communications Biology reveals that the Deep Maniot Greeks of Greece's Mani Peninsula have maintained a remarkably isolated gene pool for over a millennium. Uniparental Y‑chromosome and mitochondrial DNA analyses show continuity from Bronze Age, Iron Age...
The FDA has cleared Life Bioscience’s ER-100 for the first human trial of partial epigenetic reprogramming, aimed at restoring damaged retinal cells in patients with open‑angle glaucoma and non‑arteritic anterior ischemic optic neuropathy. The therapy delivers three Yamanaka factors—Oct4, Sox2...
Recent review highlights ferroptosis, an iron‑dependent lipid‑peroxidation cell death, as a key driver of neuronal loss in Alzheimer’s disease. Senescent cells disrupt iron homeostasis, antioxidant defenses, and autophagy, creating a pro‑ferroptotic brain environment that accelerates pathology. Physical exercise counteracts these...
Novo Nordisk is actively exploring the acquisition or internal development of a long‑acting, once‑monthly GLP‑1 therapy. The move aims to counter Pfizer’s newly launched monthly obesity injection and to broaden Novo’s weight‑loss portfolio. Executives see a monthly formulation as a...
Researchers Chen, Feng and Zhang used coronary angiography to map coronary artery lesions in children with Kawasaki disease, revealing a spectrum from mild stenosis to large aneurysms. The study identified younger age at onset and delayed IVIG treatment as key...
Anthropic has struck partnerships with the Allen Institute and the Howard Hughes Medical Institute to build AI agents that tackle biology’s growing data bottleneck. The collaborations will develop specialized agents for experiment design, data integration, and instrument control, aiming to...
Researchers demonstrated that ~25 nm polyacrylic acid‑coated MnO₂ nanoparticles can rapidly penetrate barley leaves through stomata when applied as a foliar spray. Within two hours the particles dissolve, releasing Mn²⁺ that restores photosynthetic efficiency in Mn‑deficient plants without causing phytotoxicity, even...
Researchers have engineered branched four‑way junction (4WJ) RNA nanoparticles that can conjugate up to 24 hydrophobic chemotherapeutic molecules, including camptothecin and paclitaxel. The RNA platform boosts paclitaxel’s water solubility by roughly 32,000‑fold and uses click‑chemistry ester linkers that cleave in...
Researchers engineered a nerve guidance conduit (NGC) by coating electrospun polycaprolactone (PCL) nanofibers with endothelial cell‑derived matrix (ECd). The ECd@PCL scaffold provides oriented physical cues and bioactive signals that boost axonal extension in PC12 cells and improve intercellular communication in...
Malawi’s Ministry of Health launched a nationwide performance‑management review for primary‑care facilities, integrating real‑time data dashboards and quarterly scorecards. The pilot, covering 150 clinics across three districts, showed a 12% increase in routine immunisation coverage and a 9% reduction in...
The U.S. Department of Health and Human Services is creating a generative‑AI tool to scan the Vaccine Adverse Event Reporting System (VAERS) and automatically generate hypotheses about potential vaccine injuries. The system, listed in HHS’s 2025 AI inventory, builds on...
UK Science Minister Sir Patrick Vallance confirmed that the £1 billion three‑year drug pricing deal with the United States will be funded from the Department of Health and Social Care budget, not the Treasury. The agreement keeps US tariffs on UK‑origin...
NanoSyrinx, a synthetic‑biology firm developing nanosyringe platforms for intracellular delivery, announced Thomas J. Farrell as its new Chief Executive Officer and Director, succeeding founder Joe Healey. Farrell brings more than 25 years of biotherapeutics leadership, having founded two NASDAQ‑listed companies...
Researchers at VCU Massey Cancer Center identified dronedarone, an FDA‑approved heart medication, as a selective inhibitor of the deubiquitinase USP11, targeting its non‑catalytic UBL domain. The compound, named RBF4, demonstrated potent activity against MYC‑driven diffuse large B‑cell lymphoma in preclinical...
Researchers introduced an “induced fit” growth technique that produces gallium‑based semiconductor thin films capable of atomic‑scale adaptation to substrates. The resulting films exhibit defect‑free crystal structures, high electron mobility, and robust performance under mechanical deformation, enabling flexible neuromorphic and optoelectronic...
Rare disease drug development is poised for rapid expansion, with the market projected to reach $400‑600 billion by the early‑to‑mid 2030s. Recent FDA guidances, including the plausible‑mechanism approval pathway, aim to accelerate cell and gene therapy approvals for ultrarare conditions. Executives...
In this episode, host and guest Michael Roberts, co‑founder and CEO of Adaptin Bio, discuss the difficulty of delivering biologic therapies across the blood‑brain barrier for glioblastoma patients. Roberts explains Adaptin’s platform, which reprograms a patient’s own T cells to...
Fujifilm Biotechnologies is hosting a free webinar titled “Shaping the Future of Microbial Development: From Gene to GMP.” The session, led by Steve Loftus, PhD, will showcase proven strategies and emerging technologies that accelerate microbial fermentation, scale‑up, and regulatory readiness....
Researchers at the BioInnovate Institute have unveiled a suite of engineered luciferases that emit near‑infrared light, allowing minimally invasive, high‑resolution tumor tracking in live animals. The new enzymes deliver up to three‑fold greater signal intensity than conventional firefly luciferase, while...
A new BMC Health Services Research study by Liu and Zhao examines how waiting time shapes patients' willingness to return to fever clinics in post‑epidemic China. Using empirical data from multiple clinics, the authors find that both the actual duration...
In 2021 a pandemic‑driven gold rush produced 99 biotech IPOs that raised $15.6 billion, dwarfing the combined proceeds of 2023‑24. The surge created a “logical gap,” with many companies going public before their science was mature, leading to bankruptcies, pivots, and...
Wrapping up two days at the 10th biennial International Conference on Nanoscience and Nanotechnology here in Sydney, Australia. Highly engaging event, where my participation involved serving on a panel discussion with other journal editors and delivering a plenary presentation on our...
GLP-1 earnings reports playbook: 1) $NVO: Guys, it’s not looking great for GLP-1 sellers ***$NVO and $LLY sell off*** 2) $LLY: Huh? Nah we’re good. ***$NVO stays down $LLY rips*** 3) Repeat
The U.S. Food and Drug Administration has formally asked Amgen to withdraw its rare‑disease therapy Tavneos from the market, citing unresolved safety and manufacturing concerns. Amgen’s CEO Bob Bradway publicly rejected the request, stating the company will continue to sell...
Confirmned discontinuation of $NVS PIT565, which seems to be a specifically targeted T-cell engager (also hit CD2). cf $AZN Titan platform.
$DSNKY's first DXd ADC for haematology, DS-3790, enters the clinic. As I reported last November: https://t.co/9CcbISqbqK
The spotted lanternfly, an invasive pest native to Asia, has rapidly expanded across the United States as urban environments provide ideal habitats and dispersal pathways. Cities offer abundant host trees, heat islands, and fragmented green spaces that accelerate breeding cycles...
Several scoops among the latest ADC names. Via @ApexOnco with H/T to @raffcolo -> https://t.co/JxDmId0Q0A
$MRK confirming that Interpath-001 study of $MRNA partnered intismeran autogene is "ongoing & fully enrolled". No further guidance as to timing of results, due some time in 2026. My earlier take on what to expect: https://t.co/9Pk3JK8TLs
A new epidemiological study of 5,000 Chinese adults over 60 finds a statistically significant association between chronic indoor mold exposure and increased prevalence of rheumatoid arthritis. Researchers measured mold levels using home inspections and questionnaires, linking higher spore counts to...
A new study in Reproductive Biomedicine Online warns that space’s radiation, microgravity and circadian disruption create a hostile environment for human reproduction. It highlights the absence of industry‑wide standards for managing fertility risks, early pregnancy, and ethical dilemmas as commercial...
Recent comprehensive analyses synthesize decades of neuroimaging work to map how the functional connectome of white matter evolves from childhood through late adulthood. Across longitudinal diffusion MRI and resting‑state BOLD studies, researchers observe a steady rise in inter‑regional synchrony, the...
Maternal perinatal depression (MPD) was linked to higher autistic‑related trait (ART) scores in toddlers across a Japanese cohort of 23,218 mother‑child pairs. Women with early or mid‑gestational psychological distress or postpartum depression showed 3‑4‑fold increased odds of ART overall, while...
Roche researchers have disclosed a new series of selective morpholine‑based trace amine‑associated receptor 1 (TAAR1) partial agonists that demonstrate robust antipsychotic, antidepressant and anti‑addiction activity in preclinical models. The compounds were advanced into a Phase‑1 study in healthy volunteers, where they...
A multi‑modal investigation reveals a two‑way relationship between major depressive disorder (MDD) and immune‑mediated diseases. Large cohort analyses show that depression raises the incidence of autoimmune conditions by roughly 20%, while pre‑existing autoimmune diagnoses similarly increase the risk of developing...
Representative Jake Auchincloss, a member of the House Energy and Commerce Committee, sent a formal letter to FDA Commissioner Marty Makary demanding a review of the commissioner’s national priority voucher (CNPV) program. Auchincloss argues the program, which awards expedited review...
